Difference in Estimation of Side Effects of Chemotherapy between Physicians and Patients with Early-Stage Breast Cancer: The Use of Patient Reported Outcomes (PROs) in the Evaluation of Toxicity in Everyday Clinical Practice

SIMPLE SUMMARY: Patient reported outcomes (PROs) are frequently integrated into routine toxicity monitoring in clinical studies but not so often in everyday clinical practice. Our investigation, conducted on patients with early stage breast cancer, showed disproportion between patient and physician...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavlović Mavić, Mirjana, Šeparović, Robert, Tečić Vuger, Ana, Vazdar, Ljubica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657299/
https://www.ncbi.nlm.nih.gov/pubmed/34885032
http://dx.doi.org/10.3390/cancers13235922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657299/
https://www.ncbi.nlm.nih.gov/pubmed/34885032
http://dx.doi.org/10.3390/cancers13235922

Ejemplares similares